Analysts Forecast Imminent Profitability for MeiraGTx Holdings as Growth Accelerates Industry analysts predict MeiraGTx Holdings will reach breakeven by 2026, following a projected final loss in 2025. The company’s ambitious growth rate, driven by recent partnerships and revenue surges, underpins this outlook. However, the timeline could extend if growth targets prove too optimistic, a common risk in biotech development cycles.23